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The central aim of our study was to widen the mental health response to the COVID-19 
pandemic by developing and evaluating a measure that could be used to identify the presence 
of anxiety syndrome features associated with COVID-19. In Study 1, a community sample of 
292 participants completed the newly developed COVID-19 Anxiety Syndrome Scale (C-
19ASS) and results were subjected to a Principal Components Analysis. An 11-item two-factor 
structure was identified. In Study 2, a community sample of 426 participants completed a 
battery of questionnaires including the C-19ASS. A Confirmatory Factor Analysis was 
performed on the C-19ASS. A 9-item two-factor structure was confirmed. Results also 
indicated that the C-19ASS has acceptable levels of reliability and concurrent validity. The C-
19ASS perseveration factor was found to explain an additional 9.3% variance in COVID-19 
anxiety, and additional 2.2% variance in work and social adjustment (functional impairment), 
over and above all other variables. The C-19ASS appears to be a reliable and valid measure of 
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The Coronavirus (COVID-19) pandemic has been with us since the end of 2019 (World Health 
Organization, 2020) and has brought profound changes to the way we live. These changes seem 
to have led to a surge of pandemic-related psychological distress including fear, anxiety, 
perceived threat, and stress. For example, early findings from China have suggested that more 
than one quarter of the general population experienced moderate to severe levels of stress 
and/or anxiety-related symptoms in response to COVID-19 (Qiu et al., 2020; Wang et al., 
2020). Additionally, a recent survey in the UK has indicated that during lockdown, anxiety, 
sleep difficulties, and alcohol consumption may have increased by up to 50% especially in 
those segments of the population at greater financial and health risk (Allington et al., 2020b). 
These findings align themselves to those reported during the SARS outbreak (Cheng et al., 
2004) and in the 2009 H1N1 pandemic (Rubin et al., 2009; Wheaton et al, 2012).  
Current Measures of COVID-19 Psychological Distress 
Given the role that pandemic psychological distress appears to be playing in shaping behaviour, 
it is of critical importance to understand the nature and degree of this distress. To date, key 
measures have emerged for exploring COVID-19-related fear, anxiety, threat, and stress. The 
Fear of COVID-19 Scale (Ahorsu et al., 2020) was one the first measures to tap into fear 
specific to COVID-19. Though valuable, this measure is unidimensional (i.e., focused on 
general fear aspects of COVID-19) and its development was based on a relatively limited 
psychometric evaluation More recently Lee and colleagues (Lee, 2020a, 2020b; Lee et al., 
2020a, 2020b) have developed the Coronavirus Anxiety Scale (CAS). Research has suggested 
that this measure is highly reliable and valid showing relationships with (amongst various 
variables) COVID-19 diagnosis, history of anxiety, COVID-19 fear, and functional 
impairment. The CAS has also demonstrated, importantly, solid discriminatory capability for 
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functional impairment indicating that it is a valid mental health screener for COVID-19 related 
research and practice. 
The Perceived Coronavirus Threat Questionnaire (PCTQ; Conway et al, 2020) is an 
additional recent measure which taps into threat-related thoughts and worries regarding 
COVID-19. The measure is still unpublished but has demonstrated good psychometric 
properties though further research on its predictive validity is warranted. A further recent 
measure to emerge from the literature is the COVID Stress Scales (CSS; Taylor et al., 2020). 
The CSS were developed to better understand and assess COVID-19-related distress. A stable 
5-factor solution has been identified, corresponding to scales assessing COVID-19 related 
stress and anxiety symptoms. These include danger and contamination fears, fears about 
economic consequences, xenophobia, compulsive checking and reassurance seeking, and 
traumatic stress symptoms. The CSS has performed well on various indices of reliability and 
validity and is clearly a promising measure for gaining a better and wide-ranging understanding 
of the COVID-19 stress experience. The above measures provide an invaluable resource for 
gaining a comprehensive understanding of the mental health impact of COVID-19 and all its 
authors should be commended for their prompt response in the face of this crisis. 
The COVID-19 Anxiety Syndrome 
There is a wide literature base that has shown that those suffering from pandemic-related 
psychological distress tend to exhibit elevated levels of post-traumatic stress, general stress, 
anxiety, health anxiety, and suicidality (Chong et al., 2004; Wheaton et al., 2012; Wu et al., 
2009; Yip et al., 2010) which may last well beyond the course of the pandemic.  
The eventual return to some form of ‘normal’ societal functioning is likely to entail, 
inevitably, exposure to environments associated with a greater risk of infection, such as public 
transport, offices, cinemas, and theatres. There may well be many individuals who will find it 
difficult to return to full ‘societal’ engagement because of maladaptive forms of coping that 
RUNNING HEAD: COVID-19 Anxiety Syndrome Scale 
5 
 
will have exacerbated COVID-19 anxiety (Lee, 2020b). In support of this view, very recent 
research surveying the UK population has indicated that anxiety and worry levels post-
lockdown remain considerably higher than pre-lockdown levels and may well affect 
engagement in both work and social interaction for some time to come (Allington et al., 2020a).  
We therefore think it important to identify if a COVID-19 ‘anxiety syndrome’ may be 
emerging characterized by avoidance, checking, worrying and threat monitoring (combined). 
In line with research in psychopathology (e.g. Barlow et al, 2014; Hayes, 2004; Wells, 2000) 
such constellation of maladaptive forms of coping may play a critical role in the perseveration 
of psychological distress. The COVID-19 anxiety syndrome should therefore be conceptually 
and psychometrically separate from COVID-19 threat, fear, and anxiety, which assess the 
nature of the COVID-19 threat experience rather than the response to it. Features of the 
COVID-19 anxiety syndrome have already been, but only in part, captured by Taylor and 
colleagues (2020) in the development of the CSS.  
Aims of our Study 
The central aim of our study was to widen the mental health response to the pandemic by 
developing and evaluating a brief measure that could be used to reliably identify the presence 
of anxiety syndrome features associated with COVID-19. In developing our measure, we 
wanted to tap into additional aspects of maladaptive forms of coping (e.g. avoidance, threat 
monitoring and worry) that have not been explicitly captured thus far and in a single measure. 
We hypothesized that this measure would be correlated with established measures of COVID-
19 anxiety and perceived threat. We also hypothesised that this measure would: (1) predict 
COVID-19 anxiety independently of demographics (age, gender and risk status), personality, 
and perceived COVID-19 threat; and (2) predict work and social adjustment in the new normal 
independently of demographics (age, gender and risk status), personality, perceived COVID-
19 threat, and COVID-19 anxiety. 
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Study 1: Construction of the COVID-19 Anxiety Syndrome Scale (C-19ASS) 
1. Method 
1.1 Candidate Items C-19ASS  
The C-19ASS was constructed by examining the relevant literature (e.g. Barlow et al, 2014; 
Hayes, 2004; Wells, 2000), noting aspects of the anxiety syndrome identified in other measures 
(e.g. Taylor et al., 2020), and by consulting experts in the field.  The following were the areas 
identified as potential features constituting the COVID-19 anxiety syndrome: (1) avoidance 
(e.g. of public transport because of the fear of contracting COVID-19); (2) checking (e.g. of 
symptoms of COVID-19); (3) worrying (e.g. imagining what could happen to loved ones if 
they were to contract COVID-19); and (4) threat monitoring (e.g. paying close attention to 
others displaying possible symptoms of COVID-19).  
Items were framed as statements to which participants could respond to on a five-point 
Likert-type scale to indicate their level of agreement (“1. Not at all”, “2. Rarely, less than a day 
or two”, “3. Several days”, “4. More than seven days”, and “5. Nearly every day”). The items 
were preceded by a pre-amble that read as follows: 
“A series of statements regarding people’s ways of dealing with the threat of 
coronavirus (COVID-19) are listed below. Please rate the extent to which each statement 
applies to you over the last two weeks.” 
1.2  Participants and Procedure 
A convenience sample of 292 participants (99 females; mean age = 37.2 years [SD = 
10.9; range 20 to 74 years]) was recruited for this study and completed the preliminary version 
of the COVID-19 Anxiety Syndrome Scale (C-19ASS) in the first week of June 2020. 
Participants were required to: (1) be at least 18 years of age; (2) reside in the United States; 
and (3) consent to participate. Eligibility criteria were minimal to attract a sample that 
represented a broad range of individuals. The sample reported their ethnic background as 
RUNNING HEAD: COVID-19 Anxiety Syndrome Scale 
7 
 
follows: 77.4% White, 9.6% Black, 8.6% Asian, 2.7% Mixed Race, and 1.7% Other. 80.1% of 
the sample were educated at college level, 73.3% were married, co-habiting or in a civil 
partnership, and 92.4% were employed. Approximately one third of the sample (30.5%) had 
been tested for COVID-19 while 36.6% perceived themselves to be vulnerable to the disease. 
7.2% of the sample reported having experienced bereavement as a consequence of COVID-19. 
 Participants were recruited using Amazon’s Mechanical Turk (MTurk), an internet-
based platform that allows individuals to request the completion of jobs (e.g., survey 
completion) for monetary compensation. Respondents completing surveys through MTurk 
have been found to produce high quality data and tend to be more demographically diverse 
than either standard internet samples or undergraduate samples (see Chandler and Shapiro, 
2016, for a review).  
Recruitment was limited to MTurk workers over 18 years of age and located in the 
United States. We followed Paolacci and Chandler’s (2014) recommendation and sought to 
improve data quality by restricting MTurk worker approval ratings, as research has found that 
“catch” questions do not improve data quality above and beyond recruiting MTurk workers 
with approval ratings above 95% (Peer, Vosgerau, and Acquisti, 2014). Worker specifications 
in the present study included restricting participation to MTurk workers who had approval 
ratings above 95%. 
Participants were required to provide electronic consent and there was no penalty for 
withdrawing from the study. Upon completion of the study, participants were debriefed and 
paid in full. Compensation was US$1, an amount consistent with the compensation given to 
MTurk workers completing prior studies of similar length (Buhrmester et al., 2011). The 
present research was approved by Ethics Committee of Kingston University, London, United 
Kingdom. 
 




2.1 Principal Components Analysis (PCA) 
The 11 original items (ordinal variables) of the C-19ASS were subjected to a principal 
components analysis (PCA) using SPSS (version 25; IBM Corp, 2017). Assumptions for PCA 
were met: a linear relationship between the variables was confirmed by examining the 
correlation matrix (all items were correlated at least .03 with at least one other item), the Kaiser-
Meyer-Olkin (KMO) measure of sampling adequacy was .88, and the Barlett’s test of sphericity 
was significant (<0.01) suggesting that data was suitable for reduction. The communalities 
were all above .5. The PCA revealed a two factors solution. A parallel analysis confirmed the 
two-factor solution (Henson and Roberts, 2006). We termed these two factors ‘perseveration’ 
(Factor 1) and ‘avoidance’ (Factor 2). 
We then assessed the items as indicators of the latent variables using a Promax rotation 
adopting kappa = 4. An oblique rotation was chosen as we assumed that there would be a 
correlation between the factors (as they are supposed to assess different aspects of a single 
anxiety syndrome construct).  It was decided a priori that items that loaded less than .4 on either 
factor would be discarded, as would be items that loaded above .4 on both factors. If, however, 
an item loaded more than .4 on only one factor, but the second factor loading was within .2 of 
the loading on the first factor, it would also be discarded. For example, if a factor loaded .5 on 
the first factor, it would be discarded if the loading on the second factor was above .3. This 
figure was used in order to exclude items that influenced both factors. No items met the 
exclusion criteria. This led to a two-factor solution (eigenvalues of 4.98 and 1.88) of the scores 
for the selected 11 items, which accounted for 62.3% of the variance and the estimated 
correlation between the two factors was .43 (Table 1 shows the factor loadings of the individual 
items). The 11-item C-19ASS was confirmed for the second study, where the measurement 
would be subjected to a confirmatory factor analysis using a new data set. 
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Study 2: Validation of the C-19ASS 
3. Introduction 
In order to validate the C-19ASS we: (1) determined construct validity (by running a 
Confirmatory Factor Analysis; CFA); (2) examined internal reliability; (3) established 
concurrent validity by observing whether the two factors of the C-19ASS would correlate 
significantly with established measures of COVID-19 perceived threat and anxiety; and (4) 
examined incremental validity by observing (a) whether the C-19ASS would predict levels of 
COVID-19 anxiety when controlling for key demographics (age, gender and high risk status), 
personality traits, and COVID-19 perceived threat; and (b) whether the C-19ASS would predict 
levels of work and social adjustment (functional impairment) controlling for key demographics 




A convenience sample of 426 (166 females; mean age = 38.6 years [SD = 11.2; range 20 to 75 
years]) was recruited for this study and completed a battery of questionnaires in the second 
week of June 2020. Participants were required to: (1) be at least 18 years of age; (2) reside in 
the United States (see section 5.3 for more detail); and (3) consent to participate. Eligibility 
criteria were minimal to attract a sample that represented a broad range of individuals. The 
ethnic background of this sample was as follows: 79.1% White, 9.2% Black, 5.2% Hispanic, 
3.3% Asian, 3.1%, Mixed Race, and 0.2% Other. The majority of the sample was educated at 
college level (79.4%), married, co-habiting or in a civil partnership (74.0%), and employed 
(92.0%). Approximately one third of the sample (30.0%) had been tested for COVID-19 and 
considered itself to be vulnerable to the disease (34.0%), with 4.7% having experienced a loss 
as a consequence of COVID-19. 




4.1.1 Big Five Inventory‐10 (BFI‐10; Rammstedt and John, 2007) 
This self-report measure includes 10 items, loading on five factors, assessing the Big 5 domains 
of personality: extraversion, agreeableness, conscientiousness, neuroticism, and openness to 
experience. Participants are asked to rate how well statements describe one’s personality. The 
measure is scored using a 5-point Likert scale (1 = Strongly disagree to 5 = Strongly agree) 
and scores range between 2-10 for each of the five factors. Higher scores indicate higher levels 
of a given personality trait. The BFI-10 has demonstrated good reliability and validity across 
many sample groups (Rammstedt and John, 2007). No Cronbach α was calculated in view of 
the brevity of this measure and the presence of only two items per factor (e.g. Soto and John, 
2017). However, we did calculate the Spearman-Brown coefficient for each factor as suggested 
by Eisinga, Grotenhuis, and Pelzer (2013). The coefficient was .34 for extraversion, .46 for 
agreeableness, .48 for conscientiousness, .50 for neuroticism, and .34 for openness to 
experience. 
4.1.2 Perceived Coronavirus Threat Questionnaire (PCTQ; Conway et al., 2020) 
This self-report measure includes 6 items, loading on a single factor, assessing the COVID-19 
threat perceptions (e.g., “Thinking about the Coronavirus makes me feel threatened”) and 
concerns about contracting illness (e.g. “I am stressed around other people because I worry I 
will catch the Coronavirus”). The measure is scored using a 7-point Likert scale (1 = Not true 
of me to 7 = Very true of me) and scores range between 7-49. Higher scores indicate higher 
levels of perceived COVID-19 threat. The PCTQ has demonstrated good reliability with 
validity still needing to be ascertained (Conway et al., 2020). In the current study the PCTQ 
had a Cronbach α = .84. 
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4.1.3 Coronavirus Anxiety Scale (CAS; Lee, 2020a) 
This self-report measure includes 5 items, loading on a single factor, assessing physiologically 
based symptoms that are aroused with COVID-19 related information and thoughts (e.g., “I 
felt dizzy, lightheaded, or faint, when I read or listened to news about the Coronavirus”). 
Participants are asked to rate how frequently the experience each anxiety symptom. The 
measure is scored using a 5-point time anchored scale (0 = Not at all to 4 = Nearly every day 
over the last 2 weeks) and scores range between 0-20. Higher scores indicate higher levels of 
a COVID-19 anxiety. The CAS has demonstrated good reliability and validity in a recent 
validation study (Lee et al., 2020b). In the current study the CAS had a Cronbach α = .94. 
4.1.4 Work and Social Adjustment Scale (WSAS; Mundt et al., 2002) 
An adapted version of Mundt, Marks, Shear, and Greist's (2002) WSAS was used to measure 
functional impairment. Participants were asked to rate five items of WSAS, using a 9-point 
severity scale (0 = Not at all to 8 = Very severely) with the following preamble: “Thinking 
about the COVID-19 pandemic and the way it may have impacted your mental health please 
look at each statement below and rate the extent to which the following items apply to you.” 
Higher scores indicate higher levels of a functional impairment. WSAS scores ≥ 21 suggest 
moderately severe or worse psychopathology. Therefore, using this cut score, 41.6% of the 
sample were classified as functionally impaired due to their fear or anxiety over COVID-19. 
In the current study the WSAS had a Cronbach α = .93. 
4.1.5 COVID-19 Anxiety Syndrome Scale (C-19ASS; Nikčević and Spada) 
The C-19ASS as developed in Study 1 of the current article was employed. 
4.2 Procedure 
This followed the same structure as in Study 1. 
 
 




5.1 Confirmatory Factor Analysis (CFA) 
A CFA was performed on the data obtained from the participants using a robust weighted least 
squares estimation (WLSMV).  Analysis was conducted using lavaan in R (R Core Team, 2013; 
Rosseel, 2012). We defined the latent variables as perseveration and avoidance and the 11 items 
as congeneric indicators of the latent variables. We utilized five indices to evaluate the fit of 
the model: a Chi-square measure of fit, the Comparative Fit Index (CFI), the Tucker-Lewis 
Index (TLI: also known as the Non-Normed Fit Index), the Standarized Root Mean Square 
Residual (SRMR) and the Root Mean Square Error of Approximation (RMSEA). 
The initial 11-item CFA assumed a covariance between the latent variables and resulted 
in a mixed fit: the chi-square test was significant (χ2 = 111.58, df = 43, p > .001) and the χ2/df 
= 2.59.  This model generated a CFI of 0.95, a TLI of 0.937, a SRMR of .044 and an RMSEA 
of 0.061 (90% C.I. = 0.047 – 0.075).  Parameter estimates were reviewed, and modification 
indices were calculated to generate a more parsimonious measure. Together these suggested a 
re-specified model, resulting from the removal of 2 items (#7, 8), which demonstrated a cross-
loading on the opposite factor.  The re-specified model retained the covariances between latent 
variables and good fit of the data was demonstrated on each of the measures of fit. The chi-
square test was no longer significant (χ2 = 30.44, df = 26, ns), and the resulting χ2/df = 1.17 
suggests acceptable fit (Byrne, 2001). This new model also yielded the following results: CFI 
of 0.99, TLI of 0.99, SRMR of .026 and RMSEA of 0.020 (90% C.I. = 0.000 – 0.045), 
demonstrating construct validity. Based on these results, the C-19ASS was confirmed as having 
two correlated factors, perseveration (C-19ASS-P; 6 items) and avoidance (C-19ASS-A; 3 
items). 
Cronbach’s alpha (Cronbach, 1951) was calculated using jamovi, which utilizes the 
psych package for R (R Core Team, 2013; The jamovi project, 2019). Both the C-19ASS-P (6 
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items; α = .86) and the COVID-19ASS-A (3 items; α = .77) demonstrated acceptable levels of 
reliability.  
5.2 Data Preparation and Correlation Analyses 
Table 2 shows the means, standard deviations, ranges, and inter-correlations for all the study 
variables. A series of Kolmogorov-Smirnov tests of normality were conducted on the data, which 
suggested that all measurements were normally distributed. This was confirmed by an inspection 
of skewness and kurtosis coefficients. As a result, a series of Pearson Product-Moment 
correlation analyses were conducted on the data. These revealed that: (1) the C-19ASS-P was 
positively correlated with the PCTQ and CAS; (2) the C-19ASS-A was positively correlated with 
the PCTQ but not with the CAS; (3) the C-19ASS-P was negatively correlated with the BFI-10-
Ext and BFI-10-Con, and positively correlated with the BFI-10-Neu; (4) the C-19ASS-A was 
negatively correlated with the BFI-10-Con, and positively correlated with the BFI-10-Agr and 
BFI-10-Ope; and (5) the C-19ASS-P, but not the C-19ASS, was positively correlated with the 
WSAS. 
The data also showed that the PCTQ and CAS were positively correlated. In addition, the 
CAS was negatively correlated with all the BFI-10 factors with the exception of BFI-10-Neu 
where a positive correlation was observed. The PCTQ was only positively correlated with the 
BFI-10-Neu. The WSAS was negatively correlated to all BFI-10 factors with the exception of 
BFI-10-Neu where a positive correlation was observed. A positive correlation was also observed 
between the WSAS and the PCTQ and CAS. Finally, in a separate analysis, age was found to be 
negatively correlated with WSAS (r = -.15; p = .02) but not CAS, high risk status positively 
correlated with both WSAS (r = -.32; p = .001) and CAS (r = -.32; p = .001), and gender not 
correlated with either variable. 
The absence of any correlation above .9 supported the contention that problematic 
multicollinearity would unlikely to be a problem in the regression analyses below. Histograms 
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and normality plots suggested that the residuals were normally distributed. Plots of the 
regression-standardized residuals against the regression standardized predicted values suggested 
that the assumptions of linearity and homoscedascity were met. Additionally, the Durbin-Watson 
test suggested that the assumption of independent errors was tenable. 
5.3 Hierarchical Linear Regression Analyses 
Two hierarchical linear regression analyses were conducted to determine whether the C-
19ASS-P would explain additional variance in CAS and WSAS beyond other correlated 
variables. In the first hierarchical linear regression analysis (see Table 3) CAS was the 
dependent variable and the predictor variables were entered in the following order: high risk 
status, BFI-10 factors found to be correlated with the dependent variable, PCTQ, and C-
19ASS-P (only this factor was entered as C-19ASS-A was not correlated with the dependent 
variable). This order was chosen to test whether the C-19ASS-P could predict CAS when 
controlling for all these variables. Results indicated that C-19ASS-P contributed an additional 
9.3% variance to that explained by all other variables. The final equation in Table 3 indicates 
that high risk status, BFI-10-Ext, BFI-10-Agr, BFI-10-Con and C-19ASS-P were the only 
significant predictors of CAS. 
In the second hierarchical linear regression analysis (see Table 4) WSAS was the 
dependent variable and the predictor variables were entered in the following order: age and 
high risk status, BFI-10 factors found to be correlated with the dependent variable, PCTQ, 
CAS, and C-19ASS-P (only this factor was entered as C-19ASS-A was not correlated with the 
dependent variable). This order was chosen to test whether the C-19ASS-P could predict 
WSAS when controlling for all these variables. Results indicated that C-19ASS-P contributed 
an additional 2.2% variance to that explained by all other variables. The final equation in Table 
4 indicates that high risk status, BFI-10-Agr, BFI-10-Neu, CAS and C-19ASS-P were the only 
significant predictors of WSAS. 




The central aim of our study was to widen the mental health response to the COVID-19 
pandemic by developing and evaluating a brief measure that could be used to reliably identify 
the presence of anxiety syndrome features associated with COVID-19 as we enter a period of 
graded easing of lockdown and new normal across Anglosphere countries.  
The end results of EFA and CFA yielded a 9-item measure that assesses the presence 
of perseverate thinking (6 items) and avoidance (3 items) relating to the postulated COVID-19 
anxiety syndrome. The final version of the C-19ASS demonstrated a good fit for the data and 
acceptable levels of reliability.  
A series of Pearson Product-Moment correlation analyses were conducted on the data. 
These revealed that: (1) the C-19ASS-P was positively correlated with the COVID-19 perceived 
threat and COVID-19 anxiety; and (2) the C-19ASS-A was positively correlated with the 
COVID-19 perceived threat but not with the COVID-19 anxiety. These findings broadly support 
concurrent validity of our new measure. In addition, the C-19ASS-P was found to be negatively 
correlated with the extraversion and conscientiousness, and positively correlated with the 
neuroticism. The C-19ASS-A was found to be negatively correlated with the conscientiousness, 
and positively correlated with the agreeableness and openness. These findings indicate that the 
Big 5 personality traits play a role in the COVID-19 anxiety syndrome. With respect to C-
19ASS-P, it would appear that high extraversion and conscientiousness are protective factors, 
and high neuroticism a vulnerability factor. With respect to C-19ASS-A, high conscientiousness 
is a protective factor with high agreeableness and openness vulnerability factors. Finally, C-
19ASS-P, but not C-19ASS-A, positively correlated with functional impairment. 
The data also showed that COVID-19 perceived threat and COVID-19 anxiety were 
positively correlated providing further concurrent validity for both constructs. In addition, 
COVID-19 anxiety was negatively correlated with all personality traits with the exception of 
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neuroticism where a positive correlation was observed. This finding is the first to suggest that 
COVID-19 anxiety is related to aspects of personality, broadly in line with what one would 
expect it to be: all factors being protective with the exception of neuroticism. COVID-19 
perceived threat was only positively correlated with the neuroticism, again in line with what 
would be expected. 
Functional impairment was negatively correlated to all personality traits, with the 
exception of neuroticism, where a positive correlation was observed. A positive correlation was 
also observed between functional impairment and COVID-19 perceived threat and anxiety. The 
latter finding confirms Lee and colleagues’ (2020a; 2020b) observations of the link between the 
COVID-19 anxiety and functional impairment and provides evidence that COVID-19 perceived 
threat also contributes to functional impairment. Finally, age was found to be negatively 
correlated with functional impairment but not COVID-19 anxiety, high risk status positively 
correlated with both functional impairment and COVID-19 anxiety, and gender not correlated 
with either variable. The latter finding, in particular, appears to be highly predictable in view of 
the health threat posed by COVID-19. 
Furthermore, results from two hierarchical linear regression analyses indicated C-
19ASS-P explained an additional 9.3% variance in COVID-19 anxiety, and additional 2.2% 
variance in work and social adjustment (functional impairment), over and above all other 
variables. These results, taken together, indicate that the C-19ASS may be an independent 
measure of a developing anxiety syndrome relating to COVID-19. Our findings also suggest 
the importance of personality traits in predicting both the C-19ASS-P, the COVID-19 anxiety 
and functional impairment, providing early insights into this area. It would appear that broadly 
speaking extraversion, agreeableness, openness and conscientiousness are protective factors 
and that neuroticism is a vulnerability factor.  
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An unexpected finding was that the C-19ASS-A was not correlated with either the 
COVID-19 anxiety or the functional impairment (but was with the COVID-19 perceived 
threat). A possible explanation for this is that lockdown has not been fully eased and that many 
workers have not returned to full time face to face interactions. A return to a greater face to 
face interaction (e.g. use of public transport) may bring to increases in anxiety and resultant 
avoidance. Further research will need to ascertain the relevance of the C-19ASS-A. 
Our findings align themselves to important emerging research in the field of COVID-
19 psychological distress. For example, items on the C-19ASS-P tap into obsessive thinking 
and other forms of perseveration (worry) which may lead, as Lee (2020b) has recently 
suggested, to an escalation of obsessional thinking about COVID-19 and the associated 
emergence of clinical anxiety and maladaptive coping (e.g. addictive behaviours). Other items 
of the C-19ASS-P tap into constructs which have been found to be of central importance in 
COVID-19 psychological distress, including safety behaviours (Lee et al., 2020; Taylor et al., 
2020) and excessive online information searching (Jungmann & Witthöft, 2020). 
The clinical benefits of being able to identify the COVID-19 anxiety syndrome 
(avoidance, worry, checking and threat monitoring) may be of use during the current health 
crisis (Asmundson and Taylor, 2020). For example, interventions aimed at interrupting worry 
(e.g. Metacognitive Therapy; Wells, 2000), reducing checking and avoidance (e.g. graded 
exposure and response prevention; Barlow et al., 2014) and re-calibrating attention (e.g. 
attention training technique; Wells, 2000) may serve to weaken the COVID-19 anxiety 
syndrome and possibly reduce the longer-term occurrence of psychological distress typically 
linked to pandemic events such as post-traumatic stress, general stress, anxiety, health anxiety, 
and suicidality (Chong et al., 2004; Lee, 2020b; Wheaton et al., 2012; Wu et al., 2009; Yip et 
al., 2010).  
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Limitations and Directions for Further Research 
There are several limitations that should be considered in the interpretation of these 
conclusions. First, data was solely based on self-report questionnaires, which may be subject 
to social desirability, self-report errors and poor recall. Future research could use more 
objective measures in order to ascertain the individual experience the COVID-19 anxiety 
syndrome (e.g. attentional bias). Second, this study used a cross sectional design, which does 
not allow for causal inferences. It remains unknown at present whether features of the COVID-
19 anxiety syndrome are causal to COVID-19 anxiety or epiphenomenal. Third, the 
participants in this study may not have been representative of the general population. There 
was a disproportionately higher level of male participants and the sample was overwhelmingly 
Caucasian. However, systematic research on MTurk has demonstrated that MTurk participants 
are at least as diverse as typical internet and traditional methods, and the data derived from this 
source are of high quality (Buhrmester et al., 2011). A larger sample size might have been able 
to correct for this.  
6.1 Conclusions 
Despite these above limitations, we believe that the C-19ASS is measure that could prove 
useful in better understanding a developing COVID-19 anxiety syndrome and its impact on 
COVID-19 anxiety and functional impairment. It appears the C-19ASS demonstrates 
acceptable levels of reliability and validity contributing, independently of existing measures, 
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Factor 1 Factor 2 
1. I have avoided using public transport because of the fear of 
contracting coronavirus (COVID-19). 
.38 .78 
2. I have checked myself for symptoms of coronavirus 
(COVID-19). 
.74 .37 
3. I have avoided going out to public places (shops, parks) 
because of the fear of contracting coronavirus (COVID-
19). 
.19 .84 
4. I have been concerned about not having adhered strictly to 
social distancing guidelines for coronavirus (COVID-19). 
.75 .20 
5. I have avoided touching things in public spaces because of 
the fear of contracting coronavirus (COVID-19). 
.26 .84 
6. I have read about news relating to coronavirus (COVID-
19) at the cost of engaging in work (such as writing emails, 
working on word documents or spreadsheets). 
.82 .22 
7. I have researched symptoms of coronavirus (COVID-19) at 
the cost of off-line social activities such as spending time 
with friends/family. 
.85 .29 
8. I have avoided talking about coronavirus (COVID-19). .63 -.10 
9. I have checked my family members and loved one for the 
signs of coronavirus (COVID-19). 
.74 .51 
10. I have been paying close attention to others displaying 
possible symptoms of coronavirus (COVID-19). 
.72 .44 
11. I have imagined what could happen to my family members 
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Table 2: Means, standard deviations, ranges, and inter-correlations of variables. 
 
  
X SD Range 2 3 4 5 6 7 8 9 10 11 
1. BFI-10-Ext 5.3 1.9 2-10 .24**  .30** -.23** .66** -.08 -.41** -.26** -.02 -.21** -.41** 
2. BFI-10-Agr 6.9 1.9 2-10  .38** -.29** .28** -.03 -.32** -.02 .13* .03 -.38** 
3. BFI-10-Con 7.6 1.8 3-10   -.45** -.40** -.07 -.61** -.19** -.17** -.08 -.55** 
4. BFI-10-Neu 5.2 2.0 2-10    -.25** .28** .34** .13** .03 .11* .38** 
5. BFI-10-Ope 7.0 1.8 2-10     .01 -.37** -.10 .18** .02 -.35** 
6. PCTQ 26.0 7.8 6-42      .17** .39** .47** .48** .23** 
7. CAS 5.3 5.7 0-20       .49** -.01 .37** .79** 
8. C-19ASS-P 12.2 6.2 0-24        .45** .94** .52** 
9. C-19ASS-A 8.2 3.2 0-12         .73** .02 
10. C-19ASS 20.5 8.2 0-36          .41** 
11. WSAS 15.9 11.7 0-40           
n = 426; *p < .05; **p < .01. 
Note: BFI-10-Ext = Big Five Inventory‐10-Extraversion; BFI-10-Agr = Big Five Inventory‐10-Agreeableness; BFI-10-Com = Big Five Inventory‐10-
Conscientiousness; BFI-10-Neu = Big Five Inventory‐10-Neuroticism; BFI-10-Ope = Big Five Inventory‐10-Openness; PCTQ = Perceived Coronavirus  
Threat Questionnaire; CAS = Coronavirus Anxiety Scale; C-19ASS-P = COVID-19 Anxiety Syndrome Scale-Perseveration; C-19ASS-A = COVID-




RUNNING HEAD: COVID-19 Anxiety Syndrome Scale 
21 
 
Table 3: High risk status and scores on the BFI-10 factors, the PCTQ, and the C-19ASS-P as 










Interval for B 





1 (Constant) 17.813 .943  18.897 .000 15.960 19.666 
High risk status -4.503 .546 -.372 -8.244 .000 -5.576 -3.429 
        
R =.372; R2 = .138; R2 Change = .136; p = .000 
 
2 
        
(Constant) 29.457 1.626  18.117 .000 26.261 32.654 
High risk status -2.768 .441 -.229 -6.284 .000 -3.634 -1.903 
BFI-10-Ext -.704 .145 -.229 -4.854 .000 -.990 -.419 
BFI-10-Agr -.151 .120 -.049 -1.257 .210 -.387 .085 
BFI-10-Con -1.430 .136 -.459 -10.513 .000 -1.698 -1.163 
 BFI-10-Neu .124 .115 .043 1.076 .282 -.102 .349 
 BFI-10-Ope .072 .153 .023 .474 .636 -.228 .373 
         
 R =.692; R2 = .479; R2 Change = .340; p = .000 
 
3 
        
(Constant) 28.345 1.694  16.734 .000 25.015 31.674 
High risk status -2.645 .442 -.218 -5.983 .000 -3.513 -1.776 
BFI-10-Ext -.676 .145 -.220 -4.659 .000 -.961 -.391 
BFI-10-Agr -.163 .120 -.053 -1.358 .175 -.398 .073 
BFI-10-Con -1.446 .136 -.464 -10.660 .000 -1.712 -1.179 
 BFI-10-Neu .050 .119 .018 .422 .673 -.184 .284 
 BFI-10-Ope .036 .153 .011 .232 .816 -.265 .336 
 PCTQ .061 .027 .083 2.226 .027 .007 .115 
  
 R =.696; R2 = .485; R2 Change = .006; p = .027 
 
4 
        
(Constant) 24.264 1.594  15.226 .000 21.131 27.396 
High risk status -2.217 .403 -.183 -5.500 .000 -3.010 -1.425 
BFI-10-Ext -.350 .136 -.114 -2.578 .010 -.617 -.083 
 BFI-10-Agr -.250 .109 -.081 -2.295 .022 -.464 -.036 
 BFI-10-Con -1.256 .125 -.403 -10.084 .000 -1.500 -1.011 
 BFI-10-Neu .121 .108 .042 1.116 .265 -.092 .333 
 BFI-10-Ope -.127 .140 -.041 -.910 .364 -.402 .148 
 PCTQ -.031 .027 -.042 -1.172 .242 -.084 .021 
 C-19ASS-P .324 .034 .351 9.575 .000 .257 .390 
  
 R =.760; R2 = .578; R2 Change = .093; p = .000 
         
n = 426. 
Note: BFI-10-Ext = Big Five Inventory‐10-Extraversion; BFI-10-Agr = Big Five Inventory‐10-Agreeableness; 
BFI-10-Com = Big Five Inventory‐10-Conscientiousness; BFI-10-Neu = Big Five Inventory‐10-Neuroticism; 
BFI-10-Ope = Big Five Inventory‐10-Openness; PCTQ = Perceived Coronavirus Threat Questionnaire; C-19ASS-
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Table 4: Age, high risk status, and scores on the BFI-10 factors, the PCTQ, the CAS, and the 










Interval for B 





1 (Constant) 39.356 2.914  13.505 .000 33.628 45.085 
Age -.226 .048 -.215 -4.707 .000 -.320 -.131 
High risk status -8.893 1.130 -.360 -7.871 .000 -11.114 -6.672 
        
R =.384; R2 = .147; R2 Change = .147; p = .000 
 
2 
        
(Constant) 50.712 3.841  13.203 .000 43.162 58.262 
Age -.074 .041 -.071 -1.796 .073 -.155 .007 
High risk status -4.940 .977 -.200 -5.053 .000 -6.861 -3.018 
BFI-10-Ext -1.503 .314 -.240 -4.789 .000 -2.120 -.886 
BFI-10-Agr -.536 .259 -.085 -2.067 .039 -1.045 -.026 
BFI-10-Con -2.270 .295 -.357 -7.707 .000 -2.849 -1.691 
 BFI-10-Neu .633 .248 .108 2.558 .011 .147 1.120 
 BFI-10-Ope .270 .329 .042 .823 .411 -.376 .916 
         
 R =.650; R2 = .422; R2 Change = .275; p = .000 
 
3 
        
(Constant) 46.715 3.977  11.747 .000 38.898 54.531 
Age -.063 .041 -.061 -1.556 .120 -.144 .017 
High risk status -4.482 .975 -.181 -4.596 .000 -6.399 -2.565 
BFI-10-Ext -1.418 .311 -.226 -4.557 .000 -2.029 -.806 
BFI-10-Agr -.578 .256 -.092 -2.255 .025 -1.082 -.074 
BFI-10-Con -2.328 .291 -.366 -7.987 .000 -2.901 -1.755 
 BFI-10-Neu .400 .254 .069 1.575 .116 -.099 .900 
 BFI-10-Ope .153 .327 .024 .469 .639 -.489 .795 
 PCTQ .198 .059 .131 3.359 .001 .082 .313 
  
 R =.662; R2 = .438; R2 Change = .015; p = .001 
 
4 
        
(Constant) 8.155 3.815  2.138 .033 .656 15.654 
Age -.065 .031 -.062 -2.057 .040 -.126 -.003 
High risk status -.893 .780 -.036 -1.145 .253 -2.427 .640 
BFI-10-Ext -.495 .246 -.079 -2.013 .045 -.977 -.012 
 BFI-10-Agr -.357 .198 -.057 -1.807 .072 -.746 .031 
 BFI-10-Con -.360 .253 -.057 -1.427 .154 -.857 .136 
 BFI-10-Neu .332 .196 .057 1.695 .091 -.053 .716 
 BFI-10-Ope .105 .251 .016 .417 .677 -.389 .599 
 PCTQ .115 .046 .076 2.525 .012 .026 .205 
 CAS 1.362 .080 .667 16.940 .000 1.204 1.520 
  
 R =.817; R2 = .660; R2 Change = .230; p = .000 
 
5 
        
(Constant) 9.048 3.694  2.449 .015 1.787 16.310 
Age -.058 .030 -.056 -1.918 .056 -.118 .001 
High risk status -.906 .755 -.037 -1.201 .230 -2.390 .577 
BFI-10-Ext -.277 .241 -.044 -1.148 .251 -.750 .197 
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 BFI-10-Agr -.487 .193 -.078 -2.528 .012 -.866 -.108 
 BFI-10-Con -.442 .245 -.070 -1.807 .072 -.924 .039 
 BFI-10-Neu .421 .190 .072 2.215 .027 .047 .794 
 BFI-10-Ope -.066 .245 -.010 -.271 .787 -.548 .416 
 PCTQ .026 .047 .017 .546 .586 -.067 .118 
 CAS 1.163 .086 .570 13.528 .000 .994 1.332 
 C-19ASS-P .356 .066 .189 5.428 .000 .227 .485 
  
 R =.830; R2 = .682; R2 Change = .022; p = .000 
         
n = 426. 
Note: BFI-10-Ext = Big Five Inventory‐10-Extraversion; BFI-10-Agr = Big Five Inventory‐10-Agreeableness; 
BFI-10-Com = Big Five Inventory‐10-Conscientiousness; BFI-10-Neu = Big Five Inventory‐10-Neuroticism; 
BFI-10-Ope = Big Five Inventory‐10-Openness; PCTQ = Perceived Coronavirus Threat Questionnaire; CAS = 
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COVID-19 Anxiety Syndrome Scale (C-19ASS) 
 
(Nikčević & Spada, 2020) 
 
A series of statements regarding people’s ways of dealing with the threat of coronavirus 
(COVID-19) are listed below. Please rate the extent to which each statement applies to you 
over the last two weeks.  
 
Not at all = 0  
Rarely, less than a day or two = 1 
Several days = 2 
More than 7 days = 3 
Nearly every day = 4  
 
 
1. I have avoided using public transport because of the fear of contracting coronavirus 
(COVID-19)’ 
 
2. I have checked myself for symptoms of coronavirus (COVID-19). 
 
3. I have avoided going out to public places (shops, parks) because of the fear of contracting 
coronavirus (COVID-19). 
 
4. I have been concerned about not having adhered strictly to social distancing guidelines for 
coronavirus (COVID-19). 
 
5. I have avoided touching things in public spaces because of the fear of contracting coronavirus 
(COVID-19). 
 
6. I have read about news relating to coronavirus (COVID-19) at the cost of engaging in work 
(such as writing emails, working on word documents or spreadsheets). 
 
7. I have checked my family members and loved one for the signs of coronavirus (COVID-19). 
 
8. I have been paying close attention to others displaying possible symptoms of coronavirus 
(COVID-19). 
 
9. I have imagined what could happen to my family members if they contracted coronavirus 
(COVID-19). 
 
Factor 1: 2, 4, 6, 7, 8, 9. 
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